Business Update from Health Karma(TM) CEO, Travis Jackson
FORT LAUDERDALE, FL / ACCESSWIRE / March 31, 2022 / MediXall Group Inc. (OTCQB:MDXL), an innovative healthcare solutions provider, today...
FORT LAUDERDALE, FL / ACCESSWIRE / March 31, 2022 / MediXall Group Inc. (OTCQB:MDXL), an innovative healthcare solutions provider, today...
Designed to support and enhance brain functionCHICAGO, IL / ACCESSWIRE / March 31, 2022 / Cosmos Holdings, Inc. ("the Company")...
VANCOUVER, BC / ACCESSWIRE / March 31, 2022 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is pleased to...
ZURICH, SWITZERLAND / ACCESSWIRE / March 31, 2022 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage...
VANCOUVER, BC / ACCESSWIRE / March 31, 2022 / Goodbody Health Inc. (CSE:GDBY) (OTCQB:GDBYF) ("Goodbody Health" or the "Company") is...
Bienstar Plans To Build LATAM's First Network of Integrative Mental Health ClinicsTORONTO, ON / ACCESSWIRE / March 31, 2022 /...
Mr. Dickey brings over 25 years of experience as a CFO and COO in private, public, and revenue stage companies...
Agreement grants Quadri Pharmaceuticals Store exclusive promotional, commercialization, and distribution rights in Bahrain, Kuwait, Qatar, Saudi Arabia, the United Arab...
Collaboration Eases Patient Access to TherapyLAKE FOREST, Ill., March 31, 2022 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio”) (NASDAQ: ASRT)...
Philips Ambient Experience and FlexVision display Philips Ultrasound Workspace March 31, 2022 Innovations designed to seamlessly work together, strengthen clinical...
Regenerative medicine takes aim at cancer and a wide range of other prevalent and rare diseasesWashington, DC, March 31, 2022...
NESS ZIONA, Israel, March 31, 2022 (GLOBE NEWSWIRE) -- Mapi Pharma Ltd., a fully integrated, late-stage clinical development biopharmaceutical company...
ARLINGTON, Va., March 31, 2022 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced the addition of Nancy...
Abivertinib is a novel oral small molecule tyrosine kinase inhibitor that selectively targets both mutant forms of the epidermal growth...
Phase 2 Proof-of-Concept study in TRD patients resistant to standard antidepressants suggests positive trend in efficacy.Potential first-in-class oral prolonged-release formulation...
- 2022 clinical data readouts on track to show potential best-in-class safety profile for anti-CTLA-4 programs (ADG116, ADG126) with PD-1...
NEWTON, Mass., March 31, 2022 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition,...
Odyssey Group International Announces Formation of Military Advisory Board James “Jim” Linder: Major General USA (r) Former Chief of Staff...
Shockwave M5+ IVL Catheter Broadens Options for Treatment of Peripheral ArteriesSANTA CLARA, Calif., March 31, 2022 (GLOBE NEWSWIRE) -- Shockwave...
Focus on Cancer Immunotherapy and Next-Generation Vaccines and a Strong Balance Sheet Conference Call Begins Today at 11:00 a.m. Eastern...